On 11 JUNE Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it intends to offer $175 million aggregate principal amount of convertible senior notes due 2019 in a private placement. The stock is now down 0.30 on 329K shares. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) weekly performance is -4.63%. On last trading day company shares ended up $6.38. Analysts mean target price for the company is $9.47. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -8.16%.
On 9 JUNE Telefonica S.A. (ADR) (NYSE:TEF) and Dolby Laboratories, Inc. (NYSE: DLB) have just signed a global agreement through which both companies will collaborate to drive the adoption of premium sound in smartphones. Telefónica will select the best devices from leading handset manufacturers to optimize its customers’ mobile entertainment experience through high-quality Dolby® Audio. Telefonica S.A. (ADR) (NYSE:TEF) shares advanced 0.53% in last trading session and ended the day on $16.92. TEF Gross Margin is 69.60% and its return on assets is 2.90%. Telefonica S.A. (ADR) (NYSE:TEF) quarterly performance is 15.65%.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced that the company is scheduled to present a corporate overview at the 2014 Wells Fargo Securities Healthcare Conference on Wednesday June 18 2014 at 2:25 p.m. Eastern Time (11:25 a.m. Pacific Time) at the InterContinental Hotel in Boston Massachusetts. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares moved up 1.40% in last trading session and was closed at $6.50, while trading in range of $6.32 – $6.54. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) year to date (YTD) performance is 11.11%.
On 10 JUNE Gilead Sciences, Inc. (NASDAQ:GILD) reported first quarter results. Gilead Sciences, Inc. (NASDAQ:GILD)’s revenues grew by 104% in 1Q2014 compared to 1Q2013 to reach $4.87 billion — beating estimates of $3.96 billion by 26.38% or nearly $1 billion. This spectacular growth was fueled by Gilead’s anti-viral products and above all Sovaldi, its blockbuster Hepatitis C virus (HCV). Gilead Sciences, Inc. (NASDAQ:GILD) ended the last trading day at $80.72. Company weekly volatility is calculated as 2.31% and price to cash ratio as 19.16. Gilead Sciences, Inc. (NASDAQ:GILD) showed a negative weekly performance of -2.03%.
Magyar Telekom Tavkozlesi Nyrt (ADR) (OTCMKTS: MYTAY) on last trading day company shares ended up $7.31.